Long-Term Effects of Angiotensin II Receptor Blockade with Valsartan on Carotid Arterial Stiffness and Hemodynamic Alterations in Patients with Essential Hypertension

By Okura Takafumi   Watanabe Sanae   Kurata Mie   Koresawa Mitsuko   Irita Jun   Enomoto Daijiro   Jotoku Masanori   Miyoshi Ken-Ichi   Fukuoka Tomikazu   Higaki Jitsuo  

Clinical and Experimental Hypertension, Vol. 30, Iss. 5, 2008-07 ,pp. : 415-422

Informa Healthcare

Access to resources Recommend Favorite

Effects of Selective Angiotensin II Type 1 Receptor Blockade with Losartan on Arterial Compliance in Patients with Mild Essential Hypertension

By KLEMSDAL TOR O.   MOAN ANDREAS   KJELDSEN SVERRE E.  

Blood Pressure, Vol. 8, Iss. 4, 1999-12 ,pp. : 214-219

Informa Healthcare

Access to resources Recommend Favorite

Candesartan Cilexetil, a Novel Angiotensin II Type 1 (AT1) Receptor Blocker, Reduces Microalbuminuria in Patients with Type II Diabetes Mellitus and Mild Hypertension

By TRENKWALDER P.   DAHL K.   LEHTOVIRTA M.   MULDER H.  

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 57-57

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Effects of Low Dose of Spironolactone and a Thiazide Diuretic in Patients with Hypertension Treated with an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Type 1 Receptor Blocker

By Yutaka Miyashita   Mifune Mizuo   Kubota Eiji   Itoh Hiroshi   Saito Ikuo  

Clinical and Experimental Hypertension, Vol. 31, Iss. 8, 2009-12 ,pp. : 648-656

Informa Healthcare

Access to resources Recommend Favorite

Anti-Albuminuric Effects of the Angiotensin AT1 Receptor Blocker Telmisartan in Hypertensive Patients

By Rodríguez-Pérez José C.   García-Bello Miguel A.   Anabitarte-Prieto Aránzazu   Companioni Osmel   Nóvoa-Mogollón Francisco J.   Suárez-Ortega Saturnino   Plaza-Toledano Celia   Rodríguez-Esparragón Francisco  

Clinical and Experimental Hypertension, Vol. 33, Iss. 8, 2011-12 ,pp. : 506-510

Informa Healthcare

Access to resources Recommend Favorite